抵抗素
医学
疾病
认知
生物标志物
炎症
口语流利性测试
内科学
情景记忆
认知功能衰退
阶段(地层学)
肿瘤科
血浆水平
免疫学
认知障碍
睡眠剥夺对认知功能的影响
脂肪因子
功能(生物学)
全身炎症
生物信息学
外围设备
白细胞介素6
炎症反应
作者
Emily Eruysal,Lisa Ravdin,Costantino Iadecola,Makoto Ishii
标识
DOI:10.1177/13872877261442230
摘要
Background Resistin is a circulating protein linked to systemic metabolic disorders and inflammation, both of which can contribute to the pathogenesis of Alzheimer's disease (AD). However, the role of resistin during the preclinical stage of AD and its associations with amyloid-β and tau pathology have not been established. Objective To measure plasma resistin concentrations in cognitively normal older adults and examine its association with cerebrospinal fluid (CSF) AD biomarkers and neuropsychological measures. Methods 155 (64 men and 91 women) cognitively normal (Clinical Dementia Rating 0) volunteers met all study criteria with 55 (29 men and 26 women) categorized as preclinical AD based on established CSF criteria. Plasma resistin concentrations were measured by immunoassay. Results Since plasma resistin concentrations were higher in men compared to women, all analyses were sex stratified. In men, plasma resistin concentrations were significantly higher in preclinical AD compared to biomarker negative controls and were associated with CSF concentrations of tau and p-tau 181 ; however, after correcting for multiple comparisons, there were no significant associations with any AD biomarkers. Furthermore, plasma resistin concentrations were significantly associated with semantic fluency but not with episodic memory or executive function. In women, plasma resistin concentrations were similar between preclinical AD and controls, and there were no significant associations with CSF AD biomarkers and cognitive measures. Conclusions These findings raise the possibility that, in men, alterations in peripheral resistin signaling occur during the earliest stages of AD and could represent an early link between systemic metabolic and inflammation dysregulation in AD.
科研通智能强力驱动
Strongly Powered by AbleSci AI